[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Stroke (CVA) or TIA · Carotid Artery Plaque · Atherosclerosis Cardiovascular Disease · Carotid Arteriosclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UZ Leuven, Leuven, Vlaams-Brabant, Belgium
Contact: Study coordinator (Louise Maes, MD) · louise.maes@uzleuven.be · +32 16 34 42 80
Contact: Principal Investigator (Robin Lemmens, MD PhD)

Study leads

Robin Lemmens, MD PhD
Principal Investigator
UZ Leuven

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Carotid Artery Stenosis Symptomatic · Ischemic Cerebral Infarction · Stroke Ischemic

Abroad (travel likely)Recruiting

Arnhem, Netherlands · Nijmegen, Netherlands

Trunk Impairment Scale - Adaptation and Validation in French

Stroke (CVA) or Transient Ischemic Attack · Stroke (CVA) or TIA

Abroad (travel likely)Recruiting

Ploemeur, France

Pemafibrate for Symptomatic ICAS RCT

Intracranial Atherosclerotic Disease (ICAD) · Hypertriglyceridaemia · Stroke (CVA) or TIA

Abroad (travel likely)Recruiting

Hizume, Japan · Kagoshima, Japan

Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing

Stroke · Transient Ischemic Attack (TIA)

Abroad (travel likely)Recruiting

Birmingham, United States